Revolutionary new sterility testing workstation Bioquell QUBE
Featuring proven bio-decontamination technology and flexible design, this new system offers significant efficiencies for cGMP pharmaceutical manufacturing.
By ensuring a controlled aseptic test environment, the Bioquell QUBE helps to minimise the risk of unnecessary, and costly, batch rejection due to false positive sterility test results.
The new workstation has been developed as a cost-effective, modular, barrier separation system. It incorporates Bioquell’s unique hydrogen peroxide vapour (HPV) technology to offer a rapid bio-decontamination cycle for fast and efficient transfers. HPV consistently delivers a high-level 6-log reduction in bioburden, validated by high quality HPV-optimised biological indicators. The Bioquell QUBE has been designed to accommodate a fully fitted or bench mounted sterility test unit, including the market leading Merck Millipore Steritest system. An EU GMP Grade A / ISO 5 compliant environment is ensured by both uni-directional airflow and unique isolator technology.
The intelligent modular design offers flexible configurations. If space is limited, a single module can be used. Conversely, if there is a need for high volume throughput, a three chamber workstation can be installed.
The Bioquell QUBE is the latest edition to the company’s portfolio of solutions for sterility assurance in cGMP pharmaceutical and biotechnology processes, backed by over 200 years of decontamination experience. Explore the new generation of hydrogen peroxide vapour (HPV) bio‑decontamination technologies from Bioquell at www.bioquell.com/bioquell-qube/
Tel.: +44 1264 835 835